EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Safety and efficacy of intralesional bleomycin for keloids and hypertrophic scars: A systematic review and meta‐analysis

Shun Jie You iD, Si Li iD, Chen Ming Hu iD, Fang Yu Zhong iD, Shi Han Gan iD, Yan Cai iD, Xiao Yan Xiang iD

Journal of Cosmetic Dermatology · 2024

DOI: 10.1111/jocd.16447 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Shun Jie You und 6 weiteren Autor:innen. Beteiligte Einrichtung: Plastic and Reconstructive Surgery & Burns, Affiliated Hospital of North Sichuan Medical College, Sichuan, Nanchong, China. Hauptthemen laut MEDLINE: Bleomycin, Cicatrix, Hypertrophic, Keloid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Affiliated Hospital of North Sichuan Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bleomycin, originally an antitumor drug, was explored as a pathological scar treatment in the mid‐1990s. However, its efficacy and safety profile varies among individuals.

Aims

This study aimed to assess topical bleomycin's efficacy and safety in treating hypertrophic scars and keloids.

Methods

We reviewed randomized controlled trials (RCTs) and controlled clinical trials (CCTs) published in English, comparing intralesional bleomycin to placebos or common intralesional scar treatments. Primary outcomes included percentage change in scar improvement, pigmentation, recurrence, atrophy, pain, telangiectasia, ulceration, patient self‐assessment, and observer assessment (>50%).

Results

Six trials met the criteria. Bleomycin significantly improved scar reduction compared to triamcinolone ( p < 0.05). There was no significant difference in pigmentation ( p = 0.05) and recurrence ( p = 0.21) compared to other treatments. In terms of safety, bleomycin caused less skin atrophy ( p < 0.01) and telangiectasia ( p < 0.01) but more pain ( p = 0.03) than other treatments.

Conclusions

Bleomycin was more effective than TAC, 5‐FU, or TAC combined with 5‐FU for treating keloids and hypertrophic scars with lower skin atrophy and telangiectasia risks. However, it may cause more pain than 5‐FU or TAC. Further comprehensive studies, including RCTs, are required for objective analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BleomycinCicatrix, HypertrophicKeloidHumansAntibiotics, AntineoplasticAtrophyFluorouracilInjections, IntralesionalRandomized Controlled Trials as TopicRecurrenceSkinTreatment Outcome

Stichwörter der Autor:innen

bleomycinhypertrophic scarskeloidsskin atrophytelangiectasia

Substanzen

Antibiotics, AntineoplasticBleomycinFluorouracil

Autor:innen und Institutionen

  • Plastic and Reconstructive Surgery & Burns, Affiliated Hospital of North Sichuan Medical College, Sichuan, Nanchong, China.
  • Dermatology, Affiliated Hospital of North Sichuan Medical College, Sichuan, Nanchong, China.
  • Department of Vascular Surgery Dazhou, Sichuan, Nanchong, China.
  • Genetics and Prenatal Diagnosis Center, Affiliated Hospital of North Sichuan Medical College, Sichuan, Nanchong, China.

ORCID-Profile: Shun Jie You, Si Li, Chen Ming Hu, Fang Yu Zhong, Shi Han Gan, Yan Cai, Xiao Yan Xiang

Förderung

  • Affiliated Hospital of North Sichuan Medical College

Zitieren

APA

You, S. J., Li, S., Hu, C. M., Zhong, F. Y., Gan, S. H., Cai, Y., & Xiang, X. Y. (2024). Safety and efficacy of intralesional bleomycin for keloids and hypertrophic scars: A systematic review and meta‐analysis. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16447

Vancouver

You SJ, Li S, Hu CM, Zhong FY, Gan SH, Cai Y, et al. Safety and efficacy of intralesional bleomycin for keloids and hypertrophic scars: A systematic review and meta‐analysis. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16447

BibTeX
@article{You2024,
  author = {You, Shun Jie and Li, Si and Hu, Chen Ming and Zhong, Fang Yu and Gan, Shi Han and Cai, Yan and Xiang, Xiao Yan},
  title = {Safety and efficacy of intralesional bleomycin for keloids and hypertrophic scars: A systematic review and meta‐analysis},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  doi = {10.1111/jocd.16447}
}
Kostenlos starten →